Credit Suisse Reiterates Outperform on AbCellera Biologics, Maintains $34 Price Target
Credit Suisse analyst Tiago Fauth reiterates AbCellera Biologics (NASDAQ:ABCL) with a Outperform and maintains $34 price target.
Earnings Scheduled For February 21, 2023
Companies Reporting Before The Bell
• Sohu.com (NASDAQ:SOHU) is likely to report earnings for its fourth quarter.
RCI Hospitality, AbCellera Biologics And Some Other Big Stocks Moving Higher On Thursday
U.S. stocks traded lower, with the Dow Jones dropping over 600 points on Thursday. Here are some big stocks recording gains in today’s session.
Why Planet Labs Shares Are Trading Higher; Here Are 28 Stocks Moving Premarket
Gainers
Scopus BioPharma Inc. (NASDAQ: SCPS) shares rose 74.7% to $0.4104 in pre-market trading after declining 4% on Wednesday.
Goldman Sachs Initiates Coverage On AbCellera Biologics with Buy Rating, Announces Price Target of $30
Goldman Sachs analyst Andrea Tan initiates coverage on AbCellera Biologics (NASDAQ:ABCL) with a Buy rating and announces Price Target of $30.
Why Quotient Shares Are Trading Lower By More Than 48%; Here Are 37 Stocks Moving Premarket
Gainers
Netcapital Inc. (NASDAQ: NCPL) shares rose 91.3% to $2.65 in pre-market trading following Q2 results. Netcapital posted Q2 earnings of $0.04 per share on sales of $1.78 million.
Pinterest, Oracle And Some Other Big Stocks Moving Higher In Today’s Pre-Market Session
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.
ACM Research, Inc. (NASDAQ: ACMR) shares jumped 25.9% to $10.98 in pre-market trading.
Why Magnite Shares Are Trading Higher By Over 45%? Here Are 69 Stocks Moving In Thursday’s Mid-Day Session
Gainers
Fast Radius, Inc. (NASDAQ: FSRD) shares climbed 172% to $0.2769 after dipping 40% on Wednesday. Fast Radius received Bankruptcy court approval of first day motions related to the company's voluntary Chapter 11 petitions filed on November 7.
Why Array Technologies Shares Are Trading Sharply Higher; Here Are 28 Stocks Moving Premarket
Gainers
NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) shares jumped 32% to $1.65 in pre-market trading. NeuroBo reported closing of $32.3 million underwritten public offering including full exercise of overallotment option and concurrent private placement.
Earnings Scheduled For November 8, 2022
Companies Reporting Before The Bell
• Adtran (NASDAQ:ADTN) is likely to report quarterly earnings at $0.18 per share on revenue of $330.39 million.